Factors influencing the generation of murine dendritic cells from bone marrow:: The special role of fetal calf serum

被引:31
作者
Lutz, Manfred B. [1 ]
Roessner, Susanne [2 ]
机构
[1] Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany
[2] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany
关键词
fetal calf serum; dendritic cells; culture conditions;
D O I
10.1016/j.imbio.2007.09.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since the generation of dendritic cells (DC) from myeloid precursor cells within the bone marrow (BM) was first reported, it has developed to one of the standard tools for studying DC biology in rodent systems. However, antigen-specific effects of such DC on polyclonal T cell populations may be influenced by the additional presentation of bystander antigens derived from fetal calf sera (FCS). This may lead to misinterpretations of the antigen-specific effects on the T cell response. In addition, many factors, including FCS, also influence the quantity and quality of BM-DC already during culture. Here, we review the factors that have an impact on the generation of BM-DC, including criteria regarding the mice, but also technical parameters and the different growth factors. The critical role of FCS in BM-DC cultures and alternative methods using murine sera or serum-free media are discussed. (c) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 43 条
  • [1] Austyn J M, 1998, Curr Opin Hematol, V5, P3, DOI 10.1097/00062752-199801000-00002
  • [2] Bai L, 2002, INT J ONCOL, V20, P247
  • [3] Interleukin-3Rα+ myeloid dendritic cells and mast cells develop simultaneously from different bone marrow precursors in cultures with interleukin-3
    Baumeister, T
    Rössner, S
    Pech, G
    de Bruijn, MFTR
    Leenen, PJM
    Schuler, G
    Lutz, MB
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (02) : 280 - 288
  • [4] DIFFERENTIATION OF DENDRITIC CELLS IN CULTURES OF RAT BONE-MARROW CELLS
    BOWERS, WE
    BERKOWITZ, MR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (04) : 872 - 883
  • [5] Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO
  • [6] 2-J
  • [7] TUMOR-NECROSIS-FACTOR-ALPHA COOPERATES WITH INTERLEUKIN-3 IN THE RECRUITMENT OF A PRIMITIVE SUBSET OF HUMAN CD34+ PROGENITORS
    CAUX, C
    DURAND, I
    MOREAU, I
    DUVERT, V
    SAELAND, S
    BANCHEREAU, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) : 1815 - 1820
  • [8] Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells in vivo:: A comparative analysis with Flt3 ligand
    Daro, E
    Pulendran, N
    Brasel, K
    Teepe, M
    Pettit, D
    Lynch, DH
    Vremec, D
    Robb, L
    Shortman, K
    McKenna, HJ
    Maliszewski, CR
    Maraskovsky, E
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (01) : 49 - 58
  • [9] Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains
    Feili-Hariri, M
    Morel, PA
    [J]. CLINICAL IMMUNOLOGY, 2001, 98 (01) : 133 - 142
  • [10] Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
    Haase, C
    Ejrnaes, M
    Juedes, AE
    Wolfe, T
    Markholst, H
    von Herrath, MG
    [J]. BLOOD, 2005, 106 (13) : 4225 - 4233